Back to Peptides
musclefat losslongevity

Tesamorelin + Ipamorelin Blend

Also known as Tesamorelin + Ipamorelin, Tesamorelin / Ipamorelin blend

Blended GHRH analogue and ghrelin-mimetic growth hormone secretagogue for body composition and recovery.

Medical status: Not approved as a medicine; sold as a research blend.

Also commonly used for (off-label)

  • Visceral fat loss and body recomposition
  • Growth hormone support from a single vial
  • Recovery and overnight sleep quality

Off-label and research uses are what people report, not approved indications. Talk to a clinician before using any of them.

How it's taken (route)

Documented dose
1000–2000 mcg
Typical frequency
1 time daily, 5 days on / 2 days off
Cycle
12 weeks on, 4 off
Half-life
~26–38 minutes for Tesamorelin; ~2 hours for Ipamorelin
Common vial sizes
10 mg, 20 mg
Regulatory status
Not approved for human use in most jurisdictions.

Dose on a U-100 syringe (1000–2000 mcg)

VialBAC waterDraw
10 mg2 mL20–40 units
10 mg2.5 mL25–50 units
20 mg3 mL15–30 units
20 mg5 mL25–50 units

On a U-100 syringe, 100 units = 1 mL, and the syringe holds 100 units total. Most people keep a single subcutaneous injection under about 50 units — bigger volumes are usually mixed stronger (less water) or split into two shots. Only mixes that fit in one syringe are shown. Always double-check with the reconstitution calculator.

What it does

A pre-mixed combination of Tesamorelin and Ipamorelin that targets visceral fat loss and growth hormone release together. Tesamorelin is a GHRH analogue that specifically raises growth hormone in the abdominal region, while Ipamorelin mimics ghrelin to trigger a clean GH pulse from the pituitary. The combination is used for body recomposition, visceral fat reduction, and recovery support. What people look into it for: • Reducing visceral belly fat • Supporting lean muscle and recovery • Improving sleep quality and overnight recovery • A simplified protocol from a single vial

Mechanism

Tesamorelin binds GHRH receptors to increase endogenous growth hormone secretion, with a particular effect on visceral adipose tissue. Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) to release an additional GH pulse without meaningfully raising cortisol, prolactin or hunger. The two peptides act through complementary pathways in a single injection.

Storage — lyophilisedwhat's this?

Refrigerate 2-8°C, protect from light.

Storage — reconstitutedwhat's this?

Refrigerate 2-8°C, use within ~28 days.

Reconstitution noteswhat's this?

Common mix: 10 mg total peptide blend + 2 ml bacteriostatic water = 50 mcg per unit. A 1 mg Tesamorelin dose would draw 20 units; the same volume also delivers the blended Ipamorelin component.

Commonly reported side effects

  • Injection-site redness
  • Water retention
  • Head rush
  • Hunger
  • Drowsiness
  • Tingling hands

Contraindications noted

  • Active malignancy
  • Pregnancy or breastfeeding
  • Uncontrolled diabetes

Research notes

Tesamorelin is best known for its research in HIV-associated lipodystrophy; the blend format is commonly used for convenience in body-recomposition protocols.

Track this properly

Work out syringe units with the calculator, or set up a full schedule in about a minute.

Reference information only, not medical advice. See our medical disclaimer.